Talsaclidine

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

Alzheimer DiseaseHealthy

Phase 1

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers

CompletedNCT02264067

Boehringer IngelheimHealthy

Start: 1998-07-31Updated: 2014-10-15

Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers

CompletedNCT02264093

Boehringer IngelheimHealthy

Start: 1999-11-30Updated: 2014-10-15

Phase 2

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

TerminatedNCT02249351

Boehringer IngelheimAlzheimer Disease

Start: 1999-12-31Updated: 2014-09-26

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

TerminatedNCT02248116

Boehringer IngelheimAlzheimer Disease

Start: 1999-05-31Updated: 2014-09-25